Modeling the potential clinical and economic impact of clesrovimab for the prevention of RSV in infants in England and Wales
Background Respiratory syncytial virus (RSV) infects nearly all children under two years, causing mild lower respiratory tract infections (LRTIs) although serious disease, mortality and long-term recurrent wheezing can also occur. Objectives This study evaluates the health and economic impact of various RSV prevention...